On Cancer

Search by keywords:

Show search filters

Explore by tags:

844 Blog posts found

In the Clinic

Can Cells Be Turned from Cancerous to Normal?

An experimental drug for blood cancers with certain genetic mutations is showing promise in early-stage trials.

Pictured: Eytan Stein


Each Patient Is a Unique Human Being, Not a Disease or a Group of Symptoms

MSK critical care physician Louis Voigt is a firm believer in a holistic approach to the practice of medicine, as well as to his patients and their loved ones.

Pictured: Louis Voigt


Spotlight on Pathology: A Key Component of Cancer Care

The most effective cancer treatment starts with an accurate diagnosis. Pathologist Meera Hameed explains the pathologist’s crucial contributions.

Pathologists at MSK

In the Lab

Investigators Use Stem Cells to Study Rare Pediatric Brain Tumors

Investigators have created the first-ever genetically engineered model of cancer made from human embryonic stem cells in culture.

Pictured: Viviane Tabar

In the Clinic

Restoring Limb Length Following Bone Cancer Surgery

Memorial Sloan Kettering has taken the lead in applying a limb-lengthening technique in people with bone cancer to restore long gaps in bone after removal of a tumor.

Limb lengthening


At Work: Interventional Radiologist William Alago

Interventional radiologist William Alago discusses minimally invasive procedures, advances in imaging techniques, and the future of his field.

Pictured: William Alago

In the Lab

New Findings Clarify How Immunotherapy Works — and Why, In Some People, It Doesn’t

In people with melanoma who respond to the drug ipilimumab, certain mutations make tumors more visible to the immune system.

Pictured: Jedd Wolchok, Alexandra Snyder Charen and Timothy Chan


Immunotherapy Shows Promise for Treating Solid Tumors in the Chest

A study in mouse models suggests how modified T cells may be used to treat tumors in the area just outside the lungs.

Michel Sadelain and Prasad Adusumilli


A Not-So-Stiff Upper Lip

Mustaches for Kids raises funds for Memorial Sloan Kettering’s pediatric patients in a most hairy way.

Billy Kupferman of Mustaches for Kids and Eve H.


Study Reveals How Some Breast Cancers Become Resistant to Targeted Drugs

A study of one patient’s disease has clarified why tumors stop responding to a class of experimental drugs called PI3K inhibitors.

(From left) MSK investigators Michael Berger, José Baselga, and Maurizio Scaltriti, and graduate student Pau Castel.